A new clinical trial showed positive results for patients with wet age-related macular degeneration (AMD). The study, which monitored the use and performance of Squalamine eye drops, showed improvement in a number of visual functions.
Conducted by Ohr Pharmaceutical, the nine-month research was a Phase II clinical trial that tested for the effectiveness of Squalamine eye drops in improving visual function. All patients had administered eye drops two times per day, either Squalamine or a placebo, plus injections of
Read More »
Even VIPs have eye conditions. Here’s an interesting collection of ten notables who have serious vision conditions, and who have made a success of their lives nonetheless!
1. Steve Wynn: Las Vegas casino developer and the owner of such resorts as the Wynn Las Vegas, Wynn Macau, Bellagio, The Mirage, et cetera. Wynn has developed retinitis pigmentosa which includes progressive degeneration of the photoreceptor cells of the retina. Such degeneration results in poor night vision, light to dark adaption and impaired peripheral vision. Mr. Wynn recently partnered with the University of Iowa to establish the Stephen A. Wynn Institute for Vision Research. He donated $25 million to help the university find a cure for blinding eye diseases.
Read More »
From before birth to the end of your life, smoking has a radical, nasty effect on your life: not only your health, but your social and mental life as well. It impacts every aspect of your life – your vision, your health, your happiness – from the time in the womb until your old age.
Read More »
CoQ10 is a nutrient essential to energy production in the heart. It also has the ability to improve mitochondria metabolism. Issues with mitochondria function may play a role in AMD onset. A study on this was published in Ophthalmologica in 2005.
The researchers of the study designed a trial with compounds shown to improve mitochondria function. This included CoQ10, omega-3 fatty acids, and
Read More »
Sai Chavala, MD, assistant professor of Ophthalmology and Cell Biology and director of the Laboratory for Retinal Rehabilitation at the University of North Carolina, says a class of drugs known as MDM2 inhibitors, has been successful in tests on mice for both wet and dry macular degeneration.
Macular degeneration is a major cause of vision loss, with millions worldwide affected. The part of the eye that gives us sharp, clear vision
Read More »
In this type of central vision loss, blood vessels grow at the back of the eye, which does not occur in the normal eye. The new drug-delivery system, using a biodegradable time-release coating, helped the drug stay in the eye longer.
Tests showed the drug halted the blood vessel growth in mice with similar eye conditions as people with age-related macular degeneration (AMD). If further results show it’s effective in humans, it could dramatically reduce the number of injections needed to treat the disease, lowering the risk of infection for patients.
Read More »
The potential is great for these stem cells to aid in healing damaged and diseased tissues. Not to mention most adults wouldn’t mind giving up a little extra fat for something that could save lives.
Stem cells are valued tremendously for their ability to transform into any type of tissue. The capability of the cells to grow into anything from bone to nerve to heart translates to the conceivable treatment of countless diseases. Previous research has largely been
Read More »
New evidence continues to support dietary lutein, carotenoids, zeaxanthin, and meso-zeaxanthin as a means of inhibiting development of age-related macular degeneration (AMD). AMD is the leading cause of loss of vision in Western people over age 55.
A study published in 2010, in Archives of Biochemistry and Biophysics by the Department of Ophthalmology and Visual Sciences at University of Utah, found that production of singlet oxygen in the human retinal pigment epithelium (RPE) and choroid is prevented or reduced by lutein, zeaxanthin, and meso-zeaxanthin, which act as
Read More »
A recent study linking cholesterol and macular degeneration may shed light on a highly significant problem caused by aging and potentially illuminates hope for a treatment or perhaps even a cure.
Macular degeneration is the leading cause in partial or complete blindness of adults over 60 in the United States. The disease targets the macula in the eyes which in large part is what enables us to perceive the fine detail that allows us do things like reading and driving.
A new study, published in the journal Cell Metabolism on April 2 2013, involved the study of macrophages from old mice and humans with macular degeneration. Macrophages, white blood cells that deconstruct cholesterol, have been found in higher than normal concentration in subjects with macular degeneration. In previous studies, this cellular build up has been shown
Read More »
Natural Eye Care, Inc.
3 Paradies Lane
New Paltz, New York 12561
Phone: 845.475.4158
NaturalEyeCare™ started in 1999 to help the public and professionals learn about complementary care in eye disease treatment.
The information and recommendations we offer are based on over 30 years of peer review research and personal clinical experience which guides us in providing a valuable resource to our readers, customers and patients regarding maintaining healthy vision naturally.
We believe that vision health is intimately connected to overall mental, physical and spiritual health. Therefore we encourage people to look at their overall lifestyle and diet as part of keeping healthy vision and reducing the risk of eye disease onset. This includes diet, regular exercise, and management of daily stress. If one has health issues such as high blood pressure, a thyroid imbalance, any autoimmune disease and/or are on medication(s), these possible contributions to eye disease should considered when working with your health care professional.
Please do not hesitate to call us at 845.475.4158 with any questions and concerns.
